These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8649564)

  • 1. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: A new approach to treatment.
    Yuki N
    Neurology; 1996 Jun; 46(6):1644-51. PubMed ID: 8649564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoadsorption therapy for Fisher's syndrome: analysis of the recovery process of external ophthalmoplegia and the removal ability of anti-GQ1b antibodies].
    Chida K; Watanabe S; Okita N; Takase S; Tagawa Y; Yuki N
    Rinsho Shinkeigaku; 1996 Apr; 36(4):551-6. PubMed ID: 8810848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Removal ability of IgG anti-GQ1b antibody in immunoadsorption therapy for Fisher syndrome--comparison of the removal ability between tryptophane column and phenylalanine column].
    Ichikawa H; Suzuki M; Kawamura M; Sugita K; Watanabe Y; Yuki N
    Rinsho Shinkeigaku; 1996 Feb; 36(2):323-9. PubMed ID: 8752688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoadsorption therapy for Fisher syndrome associated with IgG anti-GQ1b antibody.
    Ohtsuka K; Nakamura Y; Tagawa Y; Yuki N
    Am J Ophthalmol; 1998 Mar; 125(3):403-6. PubMed ID: 9512167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoadsorption therapy on Fisher's syndrome--removal ability of anti-ganglioside antibodies by tryptophan-linked immunoadsorbent].
    Deguchi K; Takeuchi H; Takahashi N; Yuki N
    Rinsho Shinkeigaku; 1995 Aug; 35(8):884-8. PubMed ID: 8665731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Removal ability of anti-ganglioside antibodies in immunoadsorption using a modified tryptophan-immobilized column].
    Tagawa Y; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1997 Oct; 37(10):863-7. PubMed ID: 9490893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the adsorption ability between tryptophan and modified tryptophan columns.
    Odaka M; Yuki N; Hirata K
    Ther Apher; 1997 Nov; 1(4):353-5. PubMed ID: 10225730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.
    Chiba A; Kusunoki S; Obata H; Machinami R; Kanazawa I
    Neurology; 1993 Oct; 43(10):1911-7. PubMed ID: 8413947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.
    Chiba A; Kusunoki S; Shimizu T; Kanazawa I
    Ann Neurol; 1992 Jun; 31(6):677-9. PubMed ID: 1514781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bickerstaff's brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy.
    Kikuchi M; Tagawa Y; Iwamoto H; Hoshino H; Yuki N
    J Child Neurol; 1997 Sep; 12(6):403-5. PubMed ID: 9309527
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of facial palsy during immunoadsorption plasmapheresis in Miller Fisher syndrome: a clinical report of two cases.
    Chida K; Takase S; Itoyama Y
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):399-401. PubMed ID: 9527160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of relapsing Guillain-Barré syndrome following Miller Fisher syndrome].
    Mochizuki A; Ota K; Iijima M; Yamauchi T; Iwata M
    Rinsho Shinkeigaku; 1996 May; 36(5):675-9. PubMed ID: 8905988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent presence of anti-GQ1b antibody in Fisher's syndrome.
    Yuki N; Sato S; Tsuji S; Ohsawa T; Miyatake T
    Neurology; 1993 Feb; 43(2):414-7. PubMed ID: 8437711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoadsorption therapy with TR-350 (tryptophan column) for Guillain-Barré syndrome: investigation including serum antiganglioside antibody assay].
    Araki T; Nakata H; Kusunoki S; Arai Y; Katayama Y
    Rinsho Shinkeigaku; 2000 Oct; 40(10):979-85. PubMed ID: 11296374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
    Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
    Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody.
    Yuki N
    Ann Neurol; 1996 May; 39(5):668-72. PubMed ID: 8619553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guillain-Barré syndrome associated with anti-GQ1b antibody--nosological relationship between Fisher's syndrome and Guillain-Barré syndrome].
    Jibiki T; Shimizu N; Terashima I; Yuki N
    Rinsho Shinkeigaku; 1994 Apr; 34(4):381-4. PubMed ID: 8026135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadsorption using Immusorba TR and PH.
    Hirano R; Hirata N
    Transfus Apher Sci; 2017 Oct; 56(5):661-665. PubMed ID: 28923775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-GQ1b ganglioside antibody and ophthalmoplegia of undetermined cause.
    Suzuki T; Chiba A; Kusunoki S; Chikuda M; Fujita T; Misu K
    Br J Ophthalmol; 1998 Aug; 82(8):916-8. PubMed ID: 9828777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.